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management, with absolute contraindication for early post
operative cases ie. within 3 weeks. No large randomized trials
have been reported in postoperative cases of pulmonary throm-
boembolism till date.
Aim: This retrospective study was aimed to evaluate the use of
Tenectaplase in postoperative cases of acute pulmonary
thromboembolism.
Methods: Ten post operative cases of acute pulmonary thrombo-
embolism, confirmed by CT pulmonary angiography, in which
Tenectaplase (Velix) was the drug of choice for thrombolysis were
selected (with their high risk consent). Electrocardiography, RV
dysfunction by 2D echocardiography and clinical conditions such
as tachypnea, hypotension and oxygen saturation were measured
and analyzed statistically.
Results: Initially all patients were tachypneic of which 50% had
hypotension and 9/10 had hypoxia. Thrombolytic treatment with
single intravenous bolus of Tenectaplase (30/40 mg) could signif-
icantly (p < 0.0001) improve RV function. Improvement in hypo-
tension was observed in 3/5 cases, whereas 1/9 failed to improve
hypoxia. Only 1/10 case expired due to intracranial heamorhage
immediately after thrombolysis. In one case, Tenectaplase was
given intra-arterial but the patient died after few days after IC
bleed.
Conclusion: Early diagnosis and treatment of pulmonary embo-
lism with potent thrombolytics can be life saving. Though this
study was conducted in small sample population for a short
duration the result of this study concluded that Tenectaplase can
be a potent thrombolytic agent which can be used as drug of
choice in postoperative cases of acute pulmonary thromboem-
bolism with high consent. But its potential complication and risk
factors should be managed promptly.
Reappraisal of temporal dispersion of arrhythmias
in acute myocardial infarction after thrombolysis
in initial 24 hours of presentation
Kamal Kishor, R.K. Gokhroo, Bhanwar L. Ranwa, Sajal Gupta,
Devendra Bisht, A. Avinash, Kumari Priti
Jawahar Lal Nehru Medical College, Ajmer, India
Background: Temporal dispersion of electrical instability events
and hemodynamically significant arrhythmias in myocardial
infarction (MI) after thrombolysis is not fully established.
Methods: Temporal dispersion of electrical instability events and
hemodynamically significant arrhythmias was assessed using 24
hour holter recording in 200 patients of myocardial infarction (MI)
presenting within 2 hours.
Results: Anterior wall MI had higher incidence of nonsustained
ventricular tachycardia and ventricular ectopy with marked
decrease in beat to beat (BB) variability, predisposing this group for
malignant arrhythmias. Inferior wall MI showed more bradyar-
rhythmic events and higher BB variability (P value<0.05). Electrical
instability after MI predominates in the first 8-10 hours (P value
<0.05) and tends to subside thereafter.
Ventricular ectopy, tachyarrhythmia events, bradyarrhythmia
and beat to beat variability in myocardial infarction during first 24
hour of presentation.
Conclusions: Despite the burgeoning increase in the number of MI
patients in coronary care units, vigilant monitoring is recom-
mended at least during this vulnerable period.
Characteristics AWMI (n¼86) IWMI (n-95) LWMI (n¼27)
Total Burden of hemodynamic significant tachyarrhythmia 7 (8.5%) 6 (7.6%) 2 (7.7%)
1st quartile(0-6 hr) (% of total tachyarrhythmia episode) 78% 82% 84%
2nd quartile(7-12 hr) (% of total tachyarrhythmia episode) 13% 12% 12%
3rd quartile(13-18 hr) (% of total tachyarrhythmia episode) 5% 3% 3%
4th quartile(19-24hr) (% of total tachyarrhythmia episode) 4% 3% 1%
Nonsustained VT 51 (62) 50 (57) 12 (46)
Sustained VT 8 (9.3%) 5 (5.2%) 1 (3.8%)
Ventricular fibrillation 3 (3.6%) 3 (3.3%) 1 (3.8%)
Time to onset of 1st hemodynamic significant arrhythmia
SVT/VT/VF/polymorphic VT
2.2±1.1hr 2.6±1.2 2.6±1.3hr
Burden of VE in 24 hr (% of total RR complexes)$ 13% 3.2% 2.6%
Burden of VE in 1st quartile(0-6 hr) (% of total VE) 61% 64% 73%
Burden of VE in 2nd quartile(7-12 hr) (% of total VE) 31% 28% 23%
Burden of VE in 3rd quartile(13-18 hr) (% of total VE) 5% 6% 4%
Burden of VE in 4th quartile(19-24hr) (% of total VE) 3% 2% 0%
Number of patients with bradyarrhythmia 5(6.1) 19(20.6) 1(3.8)
Bradycardia burden (bradycardia complexes as % of total RR
complexes)
1st quartile(0-6 hr) - 56 22
2nd quartile(7-12 hr) - 32 8
3rd quartile(13-18 hr) - 18 3
4th quartile(19-24hr) - 6 3
Beat to Beat RR variability(% RR>50) 7.2% 22.3% 14.8%
Beat to Beat RR variability(Magid SD) in milliseconds 40±8 50±36 54±11
Beat to Beat RR variability(Kleiger SD) in milliseconds 49±9 83±25 56±18
Beat to Beat RR variability(RMS-SD) in milliseconds 22±7 82±10 28±12
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